Zhao X - Search Results

1

Identification of PEAR1 SNPs and their influences on the variation in prasugrel pharmacodynamics.

Xiang Q, Cui Y, Zhao X, Zhao N. Xiang Q, et al. Among authors: zhao x, zhao n. Pharmacogenomics. 2013 Jul;14(10):1179-89. doi: 10.2217/pgs.13.108. Pharmacogenomics. 2013. PMID: 23859572

2

Pharmacokinetics and pharmacodynamics of single and multiple doses of prasugrel in healthy native Chinese subjects.

Cui YM, Wang ZN, Chen XW, Zhang HL, Zhao X, Zhou Y. Cui YM, et al. Among authors: zhao x. Acta Pharmacol Sin. 2012 Nov;33(11):1395-400. doi: 10.1038/aps.2012.120. Epub 2012 Oct 22. Acta Pharmacol Sin. 2012. PMID: 23085738 Free PMC article. Clinical Trial.

3

Identification of ITGA2B and ITGB3 Single-Nucleotide Polymorphisms and Their Influences on the Platelet Function.

Xiang Q, Ji SD, Zhang Z, Zhao X, Cui YM. Xiang Q, et al. Among authors: zhao x. Biomed Res Int. 2016;2016:5675084. doi: 10.1155/2016/5675084. Epub 2016 Nov 14. Biomed Res Int. 2016. PMID: 27965976 Free PMC article.

4

Candidate gene and pathway analyses identifying genetic variations associated with prasugrel pharmacokinetics and pharmacodynamics.

Liu Z, Xiang Q, Zhao X, Wang Z, Mu G, Xie Q, Zhou S, Chen S, Hu K, Xu J, Ma L, Cui Y. Liu Z, et al. Among authors: zhao x. Thromb Res. 2019 Jan;173:27-34. doi: 10.1016/j.thromres.2018.11.013. Epub 2018 Nov 15. Thromb Res. 2019. PMID: 30458339 Free article.

5

Effect of CYP2D6, CYP3A5, and MDR1 genetic polymorphisms on the pharmacokinetics of risperidone and its active moiety.

Xiang Q, Zhao X, Zhou Y, Duan JL, Cui YM. Xiang Q, et al. Among authors: zhao x. J Clin Pharmacol. 2010 Jun;50(6):659-66. doi: 10.1177/0091270009347867. Epub 2010 Mar 23. J Clin Pharmacol. 2010. PMID: 20332423 Clinical Trial.

6

The Influence of MDR1 G2677T/a genetic polymorphisms on the pharmacokinetics of repaglinide in healthy Chinese volunteers.

Xiang Q, Cui YM, Zhao X, Yan L, Zhou Y. Xiang Q, et al. Among authors: zhao x. Pharmacology. 2012;89(1-2):105-10. doi: 10.1159/000336345. Epub 2012 Mar 6. Pharmacology. 2012. PMID: 22398664 Clinical Trial.

7

The influence of UGT2B7, UGT1A8, MDR1, ALDH, ADH, CYP3A4 and CYP3A5 genetic polymorphisms on the pharmacokinetics of silodosin in healthy Chinese volunteers.

Wang Z, Xiang Q, Cui Y, Zhao X, Zhou Y. Wang Z, et al. Among authors: zhao x. Drug Metab Pharmacokinet. 2013;28(3):239-43. doi: 10.2133/dmpk.dmpk-12-rg-106. Epub 2012 Dec 18. Drug Metab Pharmacokinet. 2013. PMID: 23257391 Free article.

8

Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.

Ma L, Zhang X, Xiang Q, Zhou S, Zhao N, Xie Q, Zhao X, Zhou Y, Cui Y. Ma L, et al. Among authors: zhao x, zhao n. Basic Clin Pharmacol Toxicol. 2019 Jan;124(1):94-104. doi: 10.1111/bcpt.13111. Epub 2018 Sep 11. Basic Clin Pharmacol Toxicol. 2019. PMID: 30103286 Free article.

9

Influence of OATP1B1 and OATP1B3 mutations and glomerular filtration rate on trough serum digoxin concentration in the Chinese population: A prospective cohort study.

Chen SQ, Ding WH, Zhang N, Xiang Q, Cui YM, Zhao X. Chen SQ, et al. Among authors: zhao x. Medicine (Baltimore). 2019 Apr;98(14):e15088. doi: 10.1097/MD.0000000000015088. Medicine (Baltimore). 2019. PMID: 30946364 Free PMC article.

10

Pharmacokinetics, pharmacodynamics, tolerability and safety of single doses of bivalirudin in healthy chinese subjects.

Zhang D, Wang Z, Zhao X, Lu W, Gu J, Cui Y. Zhang D, et al. Among authors: zhao x. Biol Pharm Bull. 2011;34(12):1841-8. doi: 10.1248/bpb.34.1841. Biol Pharm Bull. 2011. PMID: 22130240 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51,097 results

Search Page

Filters